Interpace Biosciences (IDXG) Earnings Per Share (EPS)
Price: $2.005
Market Cap: $8.83M
Avg Volume: 7.93K
Market Cap: $8.83M
Avg Volume: 7.93K
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Earnings Per Share (EPS) Summary (Annual)
According to Interpace Biosciences's latest annual financial reports, the company has an earnings per share (EPS) of $0.19 and a diluted EPS of $0.18. The EPS indicates the portion of a company's profit allocated to each outstanding share of common stock, serving as an indicator of a company's profitability.
The company's EPS growth rate stands at 113.77%, and the diluted EPS growth rate is 113.04%. These metrics reflect the annual growth rate of earnings per share and diluted earnings per share over the specified period.
EPS
$0.19
Diluted EPS
$0.18
EPS Growth
113.77%
Interpace Biosciences Historical EPS
Interpace Biosciences Historical EPS Growth
EPS History
The table below shows the EPS for each year, with the latest data available for the last fiscal year 2023.
| Year | EPS | Change |
|---|---|---|
| 2023 | $0.19 | 113.77% |
| 2022 | $-1.38 | 61.34% |
| 2021 | $-3.57 | 45.08% |
| 2020 | $-6.5 | 8.58% |
| 2019 | $-7.11 | -64.20% |
| 2018 | $-4.33 | 44.27% |
| 2017 | $-7.77 | 83.06% |
| 2016 | $-45.88 | 37.48% |
| 2015 | $-73.38 | 31.97% |
| 2014 | $-107.87 | -3379.68% |
| 2013 | $-3.1 | 82.29% |
| 2012 | $-17.5 | -112.12% |
| 2011 | $-8.25 | -73.32% |
| 2010 | $-4.76 | 79.83% |
| 2009 | $-23.6 | 2.48% |
| 2008 | $-24.2 | -238.46% |
| 2007 | $-7.15 | -184.12% |
| 2006 | $8.5 | 162.18% |
| 2005 | $-13.67 | -197.64% |
| 2004 | $14 | 66.67% |
| 2003 | $8.4 | 138.32% |
| 2002 | $-21.92 | -576.52% |
| 2001 | $4.6 | -77.00% |
| 2000 | $20 | 129.89% |
| 1999 | $8.7 | -5.43% |
| 1998 | $9.2 | 289.30% |
| 1997 | $-4.86 | 0.00% |